AWTTC's horizon scanning team gathers information about new 'pipeline' medicines, indications and formulations that are in development and are expected to be licensed and made available in the UK in the next financial year.
This supports the planning, introduction and faster adoption of new medicines in NHS Wales, particularly those that may have significant cost or service planning implications.
The horizon scanning team use several sources to collect information about new medicines being developed. Pharmaceutical companies can tell AWTTC about new medicines, indications and formulations that are likely to become available for use in the UK by sending pipeline information to UK PharmaScan, or by emailing the horizon scanning team at email@example.com.
As an alternative to email, companies may wish to upload documents containing commercially sensitive information directly to the AWTTC Vault, a secure file sharing portal. Please contact us to arrange secure access to our Vault.
Our Get involved with horizon scanning page gives you more about our process and how to submit horizon scanning information.